既往腹主动脉及胸腹主动脉瘤腔内修复术后使用二次髂动脉分支装置
多中心观察性研究纳入75例既往EVAR或开窗/分支EVAR患者,因Ib型内漏或髂动脉病变进展植入88个髂动脉分支装置,技术成功率100%,住院期间重大不良事件4例(5%),5年生存率78±6%,无主动脉相关死亡,结论认为二次IBD安全有效。
要点
- 二次IBD技术成功率100%,住院期重大不良事件5%(4例),早期再干预4%(3例)。
- 5年免于再干预率85±4%,IIA不稳定3例(3%),60个月免于IIA不稳定95±3%。
- 术前肾功能不全(HR 3.4)和初次TAAA修复(HR 6.1)是远期死亡的独立因素。
核心结论
- EVAR术后二次IBD是安全有效的手术,技术成功率高、并发症率低。
- 再血管化IIA的技术选择似乎不影响早期和随访结果。
- IBD修复的长期耐久性可接受,IIA再干预率低。
研究设计与样本
- 多中心观察性研究,纳入三个欧洲中心75例患者(年龄71±9岁,96%男性),既往EVAR 64例(85%)或开窗/分支EVAR 11例(15%)。
- 共植入88个IBD,治疗髂动脉瘤样进展40例(53%)和Ib型内漏35例(47%),13例(17%)接受双侧IBD。
- IIA导管插入经腋动脉入路82例(93%)或上下贯穿技术6例(7%)。
- 主要终点为技术成功,次要终点为30天重大不良事件、早期和长期免于再干预及靶血管不稳定。
主要发现
- 所有手术技术成功(100%)。
- 住院期间重大不良事件4例(5%),早期再干预3例(4%),无死亡、卒中或既往内移植物损坏。
- 中位随访47个月(四分位距42),5年生存率78±6%,无主动脉相关死亡。
- Cox回归分析显示术前肾功能不全(HR 3.4;95%CI 1.1-10.1;p=.033)和初次TAAA修复(HR 6.1;95%CI 1.6-22.3;p=.006)是长期死亡的独立因素。
- 5年免于再干预率85±4%,再干预11例(12%)(内漏5例、IBD血栓4例、狭窄2例);IIA不稳定3条肢体(3%),60个月后免于IIA不稳定95±3%。
临床怎么用
- 原文未据此给出推荐。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
OBJECTIVE: To assess the safety and effectiveness of iliac branch devices (IBDs), as secondary procedure, for the treatment of type Ib endoleak or evolution of iliac artery disease after prior endovascular aortic repair (EVAR) for thoraco-abdominal (TAAAs) or abdominal aortic aneurysms (AAAs). METHODS: A multicentre observational study of three European centres. The study included 75 patients (age 71 ± 9 years, 96% men) with previous EVAR (n = 64, 85%) or fenestrated or branched (FB) EVAR (n = 11, 15%). Overall, 88 IBDs were implanted to treat aneurysmal iliac artery evolution in 40 (53%) and type Ib endoleak in 35 (47%) cases, respectively. Thirteen (17%) patients received bilateral IBDs. Internal iliac artery (IIA) catheterisation was done through a transaxillary access (n = 82, 93%) or up and over (n = 6, 7%) technique. The primary endpoint was technical success. Secondary endpoints were 30 day major adverse event, early and long term freedom from re-intervention and target vessel instability. RESULTS: All procedures were technically successful (100%). During hospitalisation, there were four (5%) major adverse events and three (4%) early re-interventions, but no death, stroke, or damage to previous endografts. The median follow up was 47 (interquartile range 42) months, and the five year survival rate was 78 ± 6% with no aortic related death. Cox's regression analysis showed pre-operative renal function impairment (hazard ratio [HR] 3.4; 95% confidence interval [CI] 1.1 - 10.1; p = .033), and primary TAAA repair (HR 6.1; 95% CI 1.6-22.3; p = .006) as independent factors for long term mortality. Freedom from re-interventions was 85 ± 4% at five years with 11 (12%) cases (five endoleaks, four IBD thromboses, two stenoses). IIA instability was reported in three (3%) limbs and freedom from IIA instability was 95 ± 3% after 60 months. CONCLUSION: Secondary IBD after EVAR is a safe and effective procedure with high technical success and low complication rates. The technique of choice to revascularise the IIA seems not to affect early and follow up results. Long term durability of IBD repair is acceptable with low rates of IIA re-intervention.
引用
- Spath P, Cardona-Gloria Y, Torsello G, et al. Use of Secondary Iliac Branch Devices after Previous Endovascular Abdominal and Thoraco-Abdominal Aortic Aneurysm Repair. Eur J Vasc Endovasc Surg. 2023. PMID: 36707020. doi:10.1016/j.ejvs.2023.01.033
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。